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Concurrent comparison of epidemiology, clinical
presentation and outcome between adult patients
suffering from the pandemic influenza A (H1N1) 2009
virus and the seasonal influenza A virus infection
Kelvin K W To, Samson S Y Wong, Iris W S Li, Ivan F N Hung, Herman Tse,
Patrick C Y Woo, Kwok-Hung Chan, Kwok-Yung Yuen
ABSTRACT
Purpose of study The demographics, clinical features
and outcome of patients with pandemic influenza A
(H1N1) 2009 infection were compared with a concurrent
cohort of patients with seasonal influenza A infection.
Study design The clinical and microbiological data of
hospitalised adult patients admitted between 29 June
and 28 October 2009, with pandemic A (H1N1) 2009 or
seasonal influenza A infection, were analysed.
Results A total of 186 patients including 69 pandemic A
(H1N1) and 117 seasonal influenza were analysed. The
majority (75%) under 50 years of age had pandemic A
(H1N1). Compared with seasonal influenza, pandemic A
(H1N1) patients were younger (median age 47 years vs
76 years, p<0.001), less likely to have lower respiratory
tract symptoms (46.4% vs 66.7%, p¼0.007), but more
likely to be obese (5.8% vs 0%, p¼0.018), pregnant
(7.2% vs 0.9%, p¼0.027) or have no underlying
predisposing factors (24.6% vs 5.1%, p<0.001). Patients
with pandemic A (H1N1) were more likely to receive
oseltamivir (91.3% vs 40.2%, p<0.001), but less likely to
receive antibiotics (75.4% vs 90.6%, p¼0.005).
Respiratory failure was the reason for intensive care unit
admission for all four patients with pandemic A (H1N1),
but only for one of three patients with seasonal influenza.
There were no statistical significant differences in the
rate of intensive care unit admission or death.
Conclusions In addition to age, several clinical
parameters were different between pandemic A
(H1N1) and seasonal influenza. However, since both
seasonal and pandemic influenza can lead to significant
morbidity and mortality, the impact of pre-existing
seasonal influenza should not be underestimated during
the pandemic period.
INTRODUCTION
Pandemic inﬂuenza has been considered to cause
greater morbidity and mortality than seasonal
inﬂuenza, particularly among young adults.1 In
Mexico, the rate of severe pneumonia during the
initial period of pandemic A (H1N1) 2009 was
found to be much higher than in preceding years,
with deaths predominantly occurring in the
younger age group.2 Another alarming feature of
the current pandemic inﬂuenza is that >30% of
patients with critical illness had no known predis-
posing conditions.3 A few studies involving paedi-
atric patients have undertaken a more detailed
comparison between the pandemic A (H1N1) 2009
and seasonal inﬂuenza. These studies have identi-
ﬁed older children and those with underlying
diseases to be found more frequently among
hospitalised patients with pandemic A (H1N1)
than those with seasonal inﬂuenza.4 5 The death
rate of pandemic A (H1N1) among children and
pregnant women is also higher than that of
seasonal inﬂuenza from previous years.6 7 The
major limitation of these studies is that historical
data were used for comparison. Potential biases
may arise when historical controls were used.8 For
example, the threshold for hospital admission may
vary during the pandemic and inter-pandemic
period. There have been two studies in the
southern hemisphere which concurrently compared
pandemic A (H1N1) and seasonal inﬂuenza. The
ﬁrst study, conducted in Sydney, Australia, found
that patients with pandemic A (H1N1) were
younger and less likely to be immunocompromised
than those with seasonal inﬂuenza.9 In that study,
there were no statistically signiﬁcant differences in
the clinical features and outcome between
pandemic A (H1N1) and seasonal inﬂuenza. In
contrast, a study involving eight intensive care
units (ICUs) in New South Wales, Australia,
showed that the relative risk of admission to ICU
of patients with pandemic A (H1NI) was 4.9 times
higher than for those with seasonal inﬂuenza A
infection.10
Pandemic A (H1N1) was ﬁrst introduced into
Hong Kong on 30 April 2009.11 In this study, we
sought to compare concurrently the epidemiology,
clinical features, and outcome of hospitalised
patients with pandemic and seasonal inﬂuenza. We
chose to investigate patients hospitalised during
the mitigation phase (started from 29 June 2009) to
avoid including hospital admissions for isolation
purpose only during the preceding containment
phase of the pandemic.
METHODS
Patients
This retrospective study was approved by the
institutional review board of the Hospital
Authority of Hong Kong. Patients with laboratory
conﬁrmed inﬂuenza A virus infection were identi-
ﬁed by the laboratory information system. Inclu-
sion criteria were age 18 years or above; admission
to our hospital during the 4 month period between
29 June to 28 October 2009; and positive reverse
transcriptase-polymerase chain reaction (RT-PCR)
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for inﬂuenza A virus M gene. We excluded patients electively
admitted for other medical reasons.
Clinical data collection
Clinical information was obtained from the clinical manage-
ment information system. Inﬂuenza-like illness was deﬁned as
the presence of fever and one of cough, sputum, sore throat or
rhinorrhoea. Lower respiratory tract involvement was deﬁned as
subjective shortness of breath and physical ﬁndings of wheezing
or crepitation. Cardiovascular complications were deﬁned as
acute coronary syndrome, congestive heart failure or
arrhythmia. Acute respiratory distress syndrome (ARDS) and
multiorgan failure were deﬁned using standard criteria.12 13
Myositis is deﬁned as elevation of creatine kinase >500 U/l
without elevation of the MB isoenzyme or troponin.
Laboratory investigations
The diagnosis and subtyping of inﬂuenza A virus was performed
by RT-PCR targeting the M gene, seasonal inﬂuenza A virus H1
and H3 gene, as previously described.11 14 Real-time one-step
RT-PCR assays were used for the detection of pandemic A
(H1N1) virus using Invitrogen SuperScript III Platinum One-
Step Quantitative Kit in a 7500 Sequence Detection System
(Applied Biosystem, Foster City, CA, USA). Brieﬂy, 5 ml puriﬁed
RNA was ampliﬁed in a 25 ml reaction containing 0.5 ml Super-
script III Reverse Transcriptase/Platinum Taq DNA polymerase
(Invitrogen), 0.05 ml ROX reference dye (25 mM), 12.5 ml of 2X
reaction buffer, 800 nmol/l forward primer (59- CCAAAGCT-
CAGCAAATCCTACAT-39), corresponding to nucleotides 526 to
548, 800 nmol/l reverse primer (59-GATGGTGAATGCCCCA-
TAGC-39), corresponding to nucleotides 576 to 595), and probe
200 nmol/l (Fam-TGATAAAGGGAAAGAAGTCCT-MGB),
corresponding to nucleotides 552 to 572, designed by multiple
alignment of the HA gene sequences of swine H1 virus and the
pandemic inﬂuenza A/California/04/2009 (available in
GenBank). Positive control experiments with a pandemic A
(H1N1) virus (A/California/04/2009) and negative control
experiments with seasonal A (H1N1) and A (H3N2) viruses
were performed. Reactions were ﬁrst incubated at 508C for
30 min, followed by 958C for 2 min, and were then thermal
cycled for 50 cycles (958C for 15 s, 558C for 30 s).
Viral load was determined by quantitative RT-PCR of the
inﬂuenza A virus M gene.15 Direct antigen detection by immu-
noﬂuorescence using IMAGEN respiratory screen and typing
reagents (Oxoid Ely Ltd, Ely, Cambridgeshire, UK) and viral
culture using MadineDarby canine kidney cell monolayer in
culture tubes was performed as described elsewhere.16 17
Data analysis
For comparison of pandemic and seasonal inﬂuenza, c2 or
Fisher ’s exact test were used for categorical variables, whereas
ManneWhitney U test or independent sample t test were used
for continuous variables where appropriate. Multivariate logistic
regression was performed to identify factors independently
associated with the type of inﬂuenza. SPSS 17.0 for Windows
(SPSS Inc, Chicago, Illinois, USA) was used for statistical
computation. A value of p<0.05 was considered to represent
signiﬁcant difference.
RESULTS
Patient profile
A total of 186 adult patients were included in this study, with 69
patients infected with the pandemic A (H1N1) 2009 virus, 20
patients with seasonal A (H1) virus, and 97 patients with
seasonal A (H3) virus. By comparison, data from the Centre for
Health Protection in Hong Kong showed that seasonal inﬂuenza
virus was isolated from 7366 specimens (6280 H3N2 and 1086
seasonal H1N1 virus), and pandemic A (H1N1) virus was
isolated from 22974 specimens, between July and October
2009.18 In September 2009, there was a sharp increase in the
incidence of inﬂuenza A in Hong Kong, mainly related to an
increase in pandemic A (H1N1) virus and to a lesser extent the
seasonal inﬂuenza virus H3N2.19
The majority (39/52, 75%) of patients below the age of
50 years were infected with pandemic A (H1N1), but admissions
for seasonal inﬂuenza predominated in the age group above 50
(ﬁgure 1). The median age of patients with pandemic A (H1N1)
was signiﬁcantly younger than those with seasonal inﬂuenza
(p<0.001) (table 1). In general, patients with pandemic A
(H1N1) were less likely to have underlying predisposing factors
than those with seasonal inﬂuenza (p<0.001). Speciﬁcally,
hypertension (p<0.001) or chronic neurological impairment
(p¼0.003) were less common. However, obese (p¼0.018) or
pregnant patients (p¼0.027) were more common in the
pandemic A (H1N1) cohort. There was no statistical difference
between reasons for hospital admission (table 2). Among preg-
nant women with pandemic A (H1N1), one had a spontaneous
miscarriage and another had a threatened miscarriage. One
pregnant woman with seasonal inﬂuenza was hospitalised for
decreased fetal movement. Younger age, obesity, and absence of
chronic neurological impairment were shown to be independent
underlying factors associated with pandemic A (H1N1) by
multivariate logistic regression.
Clinical features
Symptoms of inﬂuenza-like illness were more frequent in
patients with pandemic A (H1N1), although this did not reach
statistical signiﬁcance (p¼0.156) (table 2). Gastrointestinal
symptoms (vomiting or diarrhoea) were also more frequent in
patients with pandemic A (H1N1), almost reaching statistical
signiﬁcance (p¼0.050). Clinical features of lower respiratory tract
involvementwere less common among patients with pandemic A
(H1N1) (p¼0.007), but there was no signiﬁcant difference in the
frequency of pulmonary inﬁltrate on chest radiograph. There was
a wide spectrum of chest radiographic ﬁndings in both groups
of patients, which can present as lobar consolidation, diffuse
alveolar opacities or acute pulmonary oedema (ﬁgures 2e4).
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Figure 1 Age distribution of hospitalised patients infected with
pandemic influenza A (H1N1) virus and seasonal influenza virus.
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Oseltamivir was prescribed more frequently to patients with
pandemic A (H1N1), but antibiotics were prescribed more
frequently to those with seasonal inﬂuenza.
Laboratory investigations
Elevated alanine transaminase (p¼0.020) and creatinine
(p¼0.004) concentrations were more common in patients with
pandemic A (H1N1) (table 3). Viral culture was performed for all
seasonal A (H1) cases and 95 (97.9%) cases of seasonal A (H3),
with all positive viral cultures being A (H1N1) and A (H3N2),
respectively. Positive viral culture was more frequent in the
patients with pandemic A (H1N1) than seasonal inﬂuenza
(p¼0.025) (table 4), and the difference was mainly related to
a lower rate of positive viral culture for seasonal A (H3N2).
There was no signiﬁcant difference in the positive rate of direct
immunoﬂuorescence or viral load. Two patients with pandemic
A (H1N1) (Bacillus species, coagulase negative Staphylococcus)
and one patient with seasonal inﬂuenza (Micrococcus species) had
positive blood culture, but all isolates were considered to be
contamination. There was no statistically signiﬁcant difference
in the total number of positive sputum culture and bacterial
isolates between the two groups.
Intensive care admissions
Four patients with pandemic A (H1N1) infection were admitted
to the ICU. Three of them were admitted due to respiratory
failure from viral pneumonitis, two of whom developed ARDS.
The fourth patient, with end stage renal failure, was admitted to
the ICU due to acute pulmonary oedema. Of the patients with
seasonal inﬂuenza, one patient with a history of asthma was
admitted to the ICU due to severe infective exacerbation.
Another patient, a 26-year-old man with good past health, was
admitted to the ICU for close monitoring due to generalised
weakness and oxygen desaturation, but spontaneously recovered
and stayed in the ICU for only 14 h. The third patient was
Table 1 Comparison of demographics and underlying predisposing
factors between patients with pandemic A (H1N1) and seasonal
influenza
Pandemic A
(H1N1)
(n[69)
Seasonal
influenza
(n[117) p Value*
Demographics
Male sex 29 (42.0) 61 (52.1) 0.183
Age 47 (29e63) 76 (60e86) <0.001
Underlying predisposing factors
Hypertension 16 (23.2) 61 (52.1) <0.001
Chronic heart disease 10 (14.5) 31 (26.5) 0.056
Chronic lung disease 18 (26.1) 34 (29.1) 0.663
Chronic liver disease 4 (5.8) 6 (5.1) 1.000y
Chronic renal disease 6 (8.7) 9 (7.7) 0.808
Connective tissue disease 2 (2.9) 2 (1.7) 0.628y
Chronic neurologic impairment 4 (5.8) 26 (22.2) 0.003
Diabetes mellitus 12 (17.4) 27 (23.1) 0.357
Malignancy 11 (15.9) 19 (16.2) 0.958
HIV infection 0 (0) 1 (0.9) 1.000y
Transplant 4 (5.8) 3 (2.6) 0.427y
Use of immunosuppressive
drugs
6 (8.7) 6 (5.1) 0.366y
Smoker 9 (13.0) 26 (22.2) 0.122
Obesity 4 (5.8) 0 (0) 0.018y
Pregnancy 5 (7.2) 1 (0.9) 0.027y
No known predisposing factors 17 (24.6) 6 (5.1) <0.001
Data are presented as median (interquartile range) for continuous variable, and no. (%) for
categorical variables.
*c2 test was used for categorical variable and ManneWhitney U test was used for
continuous variables unless otherwise stated.
yBy Fisher’s exact test.
Table 2 Comparison of reason of admission, clinical features,
treatment and outcome between patients with pandemic A (H1N1) and
seasonal influenza
Pandemic A
(H1N1)
(n[69)
Seasonal
influenza
(n[117) p Value*
Days of symptoms before admission 2 (1e3) 1 (1e3) 0.059
Duration of hospitalisation 4 (2e7) 3 (2e6) 0.224
Reason for admission
Pulmonary symptoms 47 (68.1) 85 (72.6) 0.511
Neurological symptoms 5 (7.2) 13 (11.1) 0.389
Other symptoms 17 (24.6) 19 (16.2) 0.161
Exacerbation of underlying disease
Pulmonary disease 10 (14.5) 24 (20.5) 0.305
Other diseases 5 (7.2) 12 (10.3) 0.491
Vital signs at accident and emergency department
Hypotensionz 16 (23.2) 19 (16.2) 0.241
Pulse >100/min 32 (46.4) 48 (41.0) 0.476
Respiratory rate >20/min 14 (20.3) 28 (23.9) 0.566
Temperature $388C 34 (49.3) 62 (53.0) 0.624
Oxygen saturation <90% while
breathing ambient air
12 (17.4) 34 (29.1) 0.075
Clinical features
Influenza-like illness 58 (84.1) 88 (75.2) 0.156
Subjective fever 62 (89.9) 96 (82.1) 0.151
Sore throat or rhinorrhoea 47 (68.1) 63 (53.8) 0.056
Cough or sputum 59 (85.5) 103 (88.0) 0.619
Lower respiratory tract symptoms 32 (46.4) 78 (66.7) 0.007
Dyspnoea 27 (39.1) 55 (47.0) 0.296
Wheezing 11 (15.9) 29 (24.8) 0.156
Crepitation 25 (36.2) 49 (41.9) 0.447
Pulmonary infiltrate on chest
radiograph
25 (36.2) 52 (44.4) 0.272
Vomiting or diarrhoea 15 (21.7) 13 (11.1) 0.050
Treatment
Oseltamivir 63 (91.3) 47 (40.2) <0.001
Days of symptoms before
oseltamivir
3 (2e5) 3 (1e4) 0.252
Zanamivir 4 (5.8) 1 (0.9) 0.064y
Antibiotics 52 (75.4) 106 (90.6) 0.005
Complications
Cardiovascular 6 (8.7) 10 (8.5) 0.972
Acute respiratory distress syndrome 2 (2.9) 0 (0) 0.136y
Multiorgan failure 1 (1.4) 2 (1.7) 1.000y
Myositis 0 (0) 2 (1.7) 0.531y
ICU admission 4 (5.8) 3 (2.6) 0.427y
Duration of ICU stay (days) 2.12 (0.84e11.87) 0.96
(0.59e2.81)
0.289
Positive pressure ventilationx 4 (5.8) 4 (3.4) 0.472y
Death 2 (2.9) 7 (6.0) 0.488y
Days of symptoms before death 21 (11e31) 11 (6e21) 0.372
Data are presented as median (interquartile range) for continuous variable, and no. (%) for
categorical variables.
*c2 test was used for categorical variable and ManneWhitney U test was used for
continuous variables unless otherwise stated.
yBy Fisher’s exact test.
zSystolic blood pressure <90 mm Hg or diastolic blood pressure <60 mm Hg.
xInclude mechanical ventilation, bilevel positive airway pressure support, and continuous
positive airway pressure support.
ICU, intensive care unit.
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admitted with acute perforated duodenal ulcer, and was trans-
ferred to the ICU for postoperative care. There was no signiﬁ-
cant difference in mortality rate between patients with
pandemic A (H1N1) and those with seasonal inﬂuenza.
DISCUSSION
This study concurrently compared pandemic A (H1N1) with
seasonal inﬂuenza for hospitalised adult patients. In contrast to
seasonal inﬂuenza, those patients with pandemic A (H1N1)
were signiﬁcantly younger and less likely to have underlying
predisposing factors, but were more likely to be obese or preg-
nant. Gastrointestinal symptoms were more frequent in patients
with pandemic A (H1N1), but lower respiratory tract symptoms
were less common. Patients with seasonal inﬂuenza were less
likely to receive antiviral treatment.
As predicted from previous studies using seasonal inﬂuenza
historical controls2 and those of previous pandemics,1 our study
has conﬁrmed that patients with pandemic A (H1N1) are indeed
younger than those with seasonal inﬂuenza. The age difference
may be explained by the lack of cross-reactive antibody in the
younger population.20 On the other hand, the absolute number
of admissions was higher for patients with seasonal inﬂuenza,
especially those age 50 years or above. As a comparison, the total
number of pandemic A (H1N1) isolated by the Public Health
Laboratory Centre of Hong Kong, which receive clinical speci-
mens from both community and hospitalised patients in the
entire Hong Kong Special Administrative Region, exceed that of
seasonal inﬂuenza by more than threefold.18 The large number
of hospital admissions due to seasonal inﬂuenza is related to
seasonal A (H3), and may be due to the emergence of A/Perth/
16/2009, which is antigenically distinct from the current vaccine
strain A/Brisbane/10/2007 and A/Uruguay/716/2007.21 There-
fore, the burden on hospitals due to seasonal inﬂuenza during
the pandemic period should not be underestimated.
Our results have shown that underlying diseases were more
frequent in patients with seasonal inﬂuenza, especially hyper-
tension and chronic neurological impairment. Since these factors
may be associated with older age, we performed multivariate
logistic regression analysis, and found that only chronic neuro-
logical impairment remained signiﬁcantly associated with
seasonal inﬂuenza. As bidirectional neural-immune communi-
cation is an important aspect of the innate immune system,
damage to the brain can affect the immune response to infec-
tions, as has been demonstrated in patients with stroke.22
A caseecontrol study has found obesity to be a risk factor for
severe presentations of pandemic A (H1N1), which has not been
described for seasonal inﬂuenza.23 In our study, obese patients
were over-represented in hospitalised patients with pandemic A
(H1N1) when compared with seasonal inﬂuenza, although the
absolute number was small. In Hong Kong, the obese population
is relatively small, and may explain the lower rate of obesity in
our cohort when compared to those in western countries.24 In
addition to obesity, we have also identiﬁed pregnancy as being
more common among patients with pandemic A (H1N1) than
seasonal inﬂuenza, although multivariate logistic regression
analysis suggests that this may be related to age. Pregnancy is
a widely accepted risk factor for complications in both pandemic
and seasonal inﬂuenza,25 and studies have found that the
maternal death rate of pandemic A (H1N1) exceeds that of
seasonal inﬂuenza in preceding years.7 Documented fetal
complications of inﬂuenza include spontaneous abortion,
preterm premature rupture of membrane, and preterm labour.25
Figure 2 Chest radiograph of a patient with good past health, showing
right lower zone consolidation.
Figure 3 Chest radiographs of a patient
admitted for diabetic ketoacidosis.
(A) Chest radiograph was taken on
admission, showing early left lower zone
infiltration. (B) Rapid progression to
bilateral diffuse panlobar involvement
(chest radiograph taken 20 h after the
radiograph shown in panel A).
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It has been shown that inﬂuenza virus can infect the placenta,26
and in a recent study inﬂuenza virus was shown to replicate in
ﬁrst trimester trophoblast cell lines.27
In contrast to the study conducted by Chang et al, 9 which is
also a concurrent analysis of hospitalised patients with
pandemic A (H1N1) and seasonal inﬂuenza, our study found
several differences in the clinical features of patients with
pandemic A (H1N1) and seasonal inﬂuenza. This may be
because our study included more patients, allowing detection of
smaller differences. Another factor is that there may be differ-
ences in the criteria for hospital admissions. In our cohort,
patients with seasonal inﬂuenza were more likely to have
lower respiratory tract symptoms, but there was no statistical
difference in the frequency of pulmonary inﬁltrates on chest
radiograph. One possibility is that older patients are more
susceptible to acute bronchitis after viral infection. On the other
hand, diarrhoea or vomiting were also more common among
patients with pandemic A (H1N1), almost reaching statistical
signiﬁcance. Although the exact pathogenic mechanism of
gastrointestinal symptoms remains uncertain, this is consistent
with the results of an in vitro study which demonstrated that
more severe cytopathic effect, immunostaining and greater viral
replication occurred in intestinal cell lines for pandemic A
(H1N1) virus than seasonal inﬂuenza A virus.28 Despite
comparable rates of chronic liver and renal disease, elevated
values of both alanine transaminase and creatinine were found
more frequently in patients with pandemic A (H1N1), which
may represent a predilection for the systemic involvement of
pandemic A (H1N1) virus.
In another study using concurrent analysis of pandemic and
seasonal inﬂuenza, it has been shown that there is a higher risk
of ICU admission from pandemic A (H1N1) than seasonal
inﬂuenza.10 However, this has not been observed in our study,
and is likely related to major differences in methodology. In their
study, the denominator for the rate of ICU admission was the
total number of specimens tested positive for inﬂuenza A.
However, they did not specify whether these specimens were
collected from hospitalised patients or outpatients. In our study,
on the other hand, the denominator for the rate of ICU
admission was the number of hospitalised patients only.
Furthermore, we have also analysed the differences in the
reasons for admission to ICU. All four patients with pandemic A
(H1N1), but only one patient with seasonal inﬂuenza, were
admitted to the ICU due to severe respiratory distress. Among
those infected with pandemic A (H1N1), two had ARDS. This
ﬁnding is compatible with animal models suggesting more
severe involvement of the lower respiratory tract in pandemic A
(H1N1) than seasonal inﬂuenza virus infection.20
Oseltamivir were more frequently prescribed in patients with
pandemic A (H1N1), probably due to the perceived higher risk of
complications in this group of patients. However, most studies
of oseltamivir were performed in patients with seasonal inﬂu-
enza, and it was shown that treatment with an antiviral reduced
the mortality rate in hospitalised patients with seasonal inﬂu-
enza.29 On the other hand, antibiotics were more frequently
given to patients with seasonal inﬂuenza, although the rate of
laboratory conﬁrmed bacterial pneumonia was not statistically
different. This could be due to the higher frequency of lower
Figure 4 Chest radiographs of
a patient with congestive heart failure
and end stage renal failure due to
diabetic nephropathy. (A) Chest
radiograph taken on admission, showing
acute pulmonary oedema. (B) Persistent
right lower zone infiltrates after diuresis.
Table 3 Comparison of selected laboratory tests between patients
with pandemic A (H1N1) and seasonal influenza
Pandemic A
(H1N1)
no./total no. (%)
Seasonal influenza
no./total no. (%) p Value*
Blood tests
Leucocytosis (>10.13109/l) 16/67 (23.9) 33/116 (28.4) 0.501
Neutrophilia (>6.73109/l) 26/67 (38.8) 45/116 (38.8) 0.999
Lymphopenia (<1.23109/l) 52/67 (77.6) 94/116 (81.0) 0.579
Thrombocytopenia
(<1703109/l)
26/67 (38.8) 51/116 (44.0) 0.496
Elevated alanine transaminase
(>36 IU/l)
17/66 (25.8) 14/115 (12.2) 0.020
Elevated creatinine
(>82 mmol/l)
25/66 (37.9) 69/115 (60.0) 0.004
Elevated creatine kinase
(>161 IU/l)
9/37 (24.3) 18/54 (33.3) 0.355
Positive sputum culture 8/37 (21.6) 14/60 (23.3) 0.845
Streptococcus pneumoniae 1 2 1.000y
Staphylococcus aureus 1 0 0.371y
Haemophilus influenzae 1 2 1.000y
Moraxella catarrhalis 1 0 0.371y
Klebsiella species 2 1 0.556y
Pseudomonas aeruginosa 2 4 1.000y
Others 0 5z 0.159y
Data are presented as median (interquartile range) for continuous variable, and no. (%) for
categorical variables.
*c2 test was used for categorical variable and ManneWhitney U test was used for
continuous variables unless otherwise stated.
yBy Fisher’s exact test.
zFlavobacterium species (1), Escherichia coli (1), Candida species (2), b-haemolytic
Streptococcus and Candida species (1).
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respiratory tract symptoms in patients with seasonal inﬂuenza.
Previous studies showed that patients with acute bronchitis
were more likely to be treated with antibiotics than patients
with upper respiratory tract infections.30
Limitations
There are several limitations in our study. First, we have only
included adult patients, and therefore our ﬁndings cannot be
generalised to the whole population. If we included children, the
difference in age may even be greater because previous studies
have shown that children hospitalised for pandemic A (H1N1)
are older than those for seasonal inﬂuenza.4 Secondly, only
hospitalised patients were analysed in this study. The threshold
for admission may be inﬂuenced by age or underlying diseases.
Thirdly, as in all retrospective studies, all clinical information
was based on reviewing of clinical records. Some symptoms may
be missed because the attending physician did not elicit such
a history. However, because the diagnosis was not known at
admission for most patients, these problems affected all patients
with pandemic and seasonal inﬂuenza. Another potential limi-
tation in our study is that body height and body weight were
not recorded for most patients, and therefore some patients with
obesity may have been missed. Because antiviral treatment was
more frequently given to patients with pandemic H1N1, this
should theoretically improve the outcome of such patients, and
may affect the interpretation on the differences in outcome
between pandemic and seasonal inﬂuenza. Finally, the relatively
small sample size prohibited the detection of small differences
between the two groups.
Conclusion
By evaluating patients with pandemic and seasonal inﬂuenza
hospitalised during the same period, this study allowed us to
provide an unbiased view on the differences between infections
caused by these two types of inﬂuenza virus subtypes. Though
pandemic inﬂuenza causes great concern, especially among
healthy young adults, the impact of seasonal inﬂuenza should
not be overlooked.
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